Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Walking execution is not affected by divided attention in patients with multiple sclerosis with no disability, but there is a motor planning impairment.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Reliability and Repeatability of the Hoffmann Sign.
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
A New Method to Segment the Multiple Sclerosis Lesions on Brain Magnetic Resonance Images.
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate.
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Comment on the Paper by Esen et al. Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Burden and cost of neurological diseases: a European North-South comparison.
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases.
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.
[Guillain-Barré syndrome with dysphagia after frontal sinusitis.]
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Is electroconvulsive therapy safe in multiple sclerosis?
Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Pages
« first
‹ previous
…
643
644
645
646
647
648
649
650
651
…
next ›
last »